Tag USA

Biosimilars & Biobetters USA Industry Leaders Will Meet in Iselin, New Jersey, in April 2014

Dec9

Iselin, New Jersey, USA (PRWEB UK) 9 December 2013 After the phenomenal success of our Biosimilars and Biobetters event hosted in London in October, the SMi Group is delighted to announce the launch of the Biosimilars & Biobetters Conference in Iselin, New Jersey, USA, in April 2014. Registration is now open.Through a series of exciting […]

Canadian Pharmacy’s 30,000+ Online Reviews Give It Top Ratings Among Canadian Online Pharmacies

Oct10

(PRWEB) October 10, 2011A reputable Canada pharmacy online, NorthWestPharmacy.com, has earned a five out of five star rating from tens of thousands of its customers, making NorthWestPharmacy.com the most independently five star rated Canadian online pharmacy in the world. In the last 10 months alone, more than 31,000 customers have rated this Canadian pharmacy online […]

DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

Apricus Biosciences, Inc.31.08.2011 15:47-SAN DIEGO, 2011-08-31 15:47 CEST (GLOBE NEWSWIRE) Apricus Biosciences, Inc. (‘Apricus Bio’ or the ‘Company’) (Nasdaq:APRI)(http://www.apricusbio.com) announced today that its wholly-owned subsidiary,NexMed USA, Inc., has received clearance from the U.S. Food and DrugAdministration (‘FDA’) for its third, over-the-counter (‘OTC’) drug,Diphenhydramine-D(tm), containing the Company’s NexACT(r) technology.’This latest clearance from the FDA of our […]

Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

SAN DIEGO, Aug. 31, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly-owned subsidiary, NexMed USA, Inc., has received clearance from the U.S. Food and Drug Administration ("FDA") for its third, over-the-counter ("OTC") drug, Diphenhydramine-D?, containing the Company’s NexACT technology."This latest clearance from the FDA of […]

Apricus Biosciences Announces FDA Clearance for Its Second OTC Anti-Itch Drug (Hydrocortisone-D Containing NexACT Technology

Aug23

Apricus Biosciences (Nasdaq: APRI) announced today that its wholly owned subsidiary, NexMed USA, has received clearance from the U.S. Food and Drug Administration ("FDA") to market its second, over-the-counter ("OTC") anti-itch drug, Hydrocortisone-D?, containing the Company’s NexACT technology."This is the second clearance by the FDA of a drug containing Apricus Bio’s NexACT drug delivery technology, […]

Apricus Biosciences Announces FDA Clearance for Its Second OTC Anti-Itch Drug (Hydrocortisone-D(TM)) Containing NexACT(R) Technology

Aug23

SAN DIEGO, Aug. 23, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly owned subsidiary, NexMed USA, has received clearance from the U.S. Food and Drug Administration ("FDA") to market its second, over-the-counter ("OTC") anti-itch drug, Hydrocortisone-D?, containing the Company’s NexACT technology. "This is the second […]

Photo Release Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

Aug18

DDAIP Now Listed on U.S. Monograph for OTC Products SAN DIEGO, Aug. 18, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly owned subsidiary, NexMed USA, has received clearance from the U.S. Food and Drug Administration ("FDA") to market its first anti-fungal, over-the-counter ("OTC") drug, Tolnaftate-D?, […]

Federal Register Table of Contents

Aug18

Citation: "76 FR III"Page Number: "III""Table of Contents"Table of Contents Office of the Federal Register Agricultural Marketing ServiceNOTICESUnited States Standards for Grades of Grapefruit Juice , 51343Agriculture Department SeeAgricultural Marketing Service SeeFood and Nutrition Service SeeForest Service SeeRural Housing ServiceArchitectural and Transportation Barriers Compliance BoardNOTICESMeetings: Accessibility Committee of the Federal Chief Information Officers Council , […]

Bioject Reports Second Quarter 2011 Financial Results

Aug10

Revenue Doubles Over Second Quarter 2010 PORTLAND, Ore.(BUSINESS WIRE) Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2011. Bioject reported revenues of $2.4 million for the quarter ended June 30, 2011, compared to revenues of $1.2 million in the […]

Research and Markets: Drug Delivery Devices Market Outlook in Austria to 2017

Aug3

Dublin – Research and Markets has announced the addition of GlobalData ‘s new report "Drug Delivery Devices Market Outlook in Austria to 2017 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" to their offering.The new report, Drug Delivery Devices Market Outlook in Austria to 2017 – Metered Dose Inhaler […]